In The News

Wistar secures $4.7M to develop Epstein-Barr-related cancer drug

The Seeding Drug Discovery Award of up to $4.7 million is to aid the translational research being carried out by Paul M. Lieberman, a professor at Wistar. Lieberman leads the Center for Chemical Biology and Translational Medicine at Wistar, a partnership between Wistar and University of the Sciences in Philadelphia.

Read more: http://www.medcitynews.com/2011/12/wistar-institute-secures-4-7-mil-for-epstein-barr-related-cancer-drug/

Philly.com: Wistar Institute to break ground on new research tower

Scientists will collaborate in the new facility, but the Internet will mean more work with colleagues in Asia and Europe. Kaufman also hopes Wistar, Penn, Drexel, the University of the Sciences, and other health-oriented research facilities will help Philadelphia remain - and increase its status as - a hub for high-end research.

Read more: http://www.philly.com/philly/business/20110923_Wistar_Institute_to_break_ground_on_new_research_tower.html